Cellosaurus G-361 (CVCL_1220)

Cell line name G-361
Synonyms G361; G361-mel; G361mel
Accession CVCL_1220
Resource Identification Initiative To cite this cell line use: G-361 (RRID:CVCL_1220)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: MD Anderson Cell Lines Project.
Microsatellite instability: Stable (MSS) (Sanger).
Sequence variation: Heterozygous for BRAF p.Val600Glu (ATCC).
Omics: Deep exome analysis.
Omics: Deep RNAseq analysis.
Omics: DNA methylation analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children: CVCL_4Y12 (G-361/CMV-Luc); CVCL_JG86 (G-361/CMV-Luc#2(c-2.5)); CVCL_IW13 (G361/R)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=25877200; RCB

Markers:
AmelogeninX
CSF1PO10
D13S31711
D16S53915
D18S5115,16
D21S1129,30
D3S135816 (KCLB)
11,16 (PubMed=25877200)
D5S81811
D7S8208,11
D8S117912,13
FGA19,21
Penta D9,10,11
Penta E10,14
TH017,9
TPOX8,10
vWA15,17
Web pages http://tcpaportal.org/mclp/
Publications

DOI=10.1203/00006450-197804001-00732
Peebles P.T., Trisch T., Papageorge A.G.
Isolation of four unusual pediatric solid tumor cell lines.
Pediatr. Res. 12:485-485(1978)

PubMed=2174414; DOI=10.1002/ijc.2910460629
Deschodt-Lanckman M., Vanneste Y., Loir B., Michel A., Libert A., Ghanem G., Lejeune F.
Degradation of alpha-melanocyte stimulating hormone (alpha-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture.
Int. J. Cancer 46:1124-1130(1990)

PubMed=15467732; DOI=10.1038/sj.onc.1208152
Tanami H., Imoto I., Hirasawa A., Yuki Y., Sonoda I., Inoue J., Yasui K., Misawa-Furihata A., Kawakami Y., Inazawa J.
Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Oncogene 23:8796-8804(2004)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z., Liu H., Degenhardt J., Mayba O., Gnad F., Liu J., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

Cross-references
Cell line collections ATCC; CRL-1424
ECACC; 88030401
ICLC; HTL99001
IFO; IFO50009
JCRB; JCRB9074
KCLB; 21424
RCB; RCB0991
Cell line databases/resources CLDB; cl1407
CLDB; cl1408
CLDB; cl4941
CCLE; G361_SKIN
CGH-DB; 9315-4
Cosmic-CLP; 906865
GDSC; 906865
LINCS_LDP; LCL-1246
Lonza; 987
Ontologies BTO; BTO:0001584
CLO; CLO_0003433
CLO; CLO_0050698
EFO; EFO_0006394
Biological sample resources BioSample; SAMN01821552
BioSample; SAMN01821727
BioSample; SAMN03471453
BioSample; SAMN03472419
Chemistry resources ChEMBL-Cells; CHEMBL3307514
ChEMBL-Targets; CHEMBL614036
Gene expression databases GEO; GSM206469
GEO; GSM274684
GEO; GSM827495
GEO; GSM887016
GEO; GSM888085
GEO; GSM1374482
GEO; GSM1669798
Polymorphism and mutation databases Cosmic; 687435
Cosmic; 874385
Cosmic; 905228
Cosmic; 906865
Cosmic; 928692
Cosmic; 933005
Cosmic; 1006557
Cosmic; 1007157
Cosmic; 1022275
Cosmic; 1155277
Cosmic; 1459650
Cosmic; 1995409
Cosmic; 2036701
Cosmic; 2159446
Cosmic; 2630487